Stockscreener 앱 받기
4.03
3.59%
-0.15
시간 외 거래:
4.10
0.07
+1.74%
전일 마감가:
$4.18
열려 있는:
$4.05
하루 거래량:
462.28K
Relative Volume:
0.55
시가총액:
$453.37M
수익:
$69.56M
순이익/손실:
$-240.05M
주가수익비율:
-1.3661
EPS:
-2.95
순현금흐름:
$-121.90M
1주 성능:
-9.03%
1개월 성능:
-1.23%
6개월 성능:
+179.86%
1년 성능:
+33.44%
1일 변동 폭
$4.02
$4.185
1주일 범위
$4.02
$4.80
52주 변동 폭
$1.05
$4.80
Adc Therapeutics Sa Stock (ADCT) Company Profile
명칭
Adc Therapeutics Sa
전화
41 21 653 02 00
주소
BIOPOLE, EPALINGES
ADCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
4.03 | 470.25M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-03-28 | 개시 | Guggenheim | Buy |
| 2023-08-10 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-04-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-12-06 | 개시 | CapitalOne | Overweight |
| 2022-11-09 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-09-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-08-17 | 재개 | Jefferies | Buy |
| 2021-08-09 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 개시 | Stifel | Hold |
| 2020-10-29 | 개시 | H.C. Wainwright | Buy |
| 2020-06-09 | 개시 | BofA/Merrill | Buy |
| 2020-06-09 | 개시 | Cowen | Outperform |
모두보기
Adc Therapeutics Sa 주식(ADCT)의 최신 뉴스
Will ADC Therapeutics SA Common Shares stock boost dividends furtherQuarterly Trade Report & Technical Pattern Recognition Alerts - newser.com
Is ADC Therapeutics SA stock a defensive play in 2025Risk Management & Consistent Profit Alerts - newser.com
Is ADC Therapeutics SA stock a top pick in earnings season2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Will ADC Therapeutics SA stock deliver long term returns2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com
Is ADC Therapeutics SA Common Shares stock trading at attractive multiplesMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025 - BioSpace
Using AI based signals to follow ADC Therapeutics SAMarket Movement Recap & Safe Entry Momentum Tips - newser.com
How institutional ownership impacts ADC Therapeutics SA stockTrade Risk Assessment & High Conviction Buy Zone Alerts - newser.com
Is ADC Therapeutics SA stock dividend yield sustainable2025 AllTime Highs & High Accuracy Swing Trade Signals - newser.com
What insider trading reveals about ADC Therapeutics SA stockTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Is ADC Therapeutics SA stock attractive for long term wealth buildingEarnings Performance Report & AI Driven Stock Movement Reports - newser.com
What earnings revisions data tells us about ADC Therapeutics SAVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
ADC Therapeutics (NYSE: ADCT) to host results call Nov. 10 with live webcast - Stock Titan
ADC Therapeutics SA stock chart pattern explainedJuly 2025 Momentum & Low Drawdown Momentum Trade Ideas - newser.com
Is it time to cut losses on ADC Therapeutics SAWeekly Loss Report & AI Driven Price Predictions - newser.com
Momentum divergence signals in ADC Therapeutics SA chartStop Loss & Real-Time Volume Surge Alerts - newser.com
Will ADC Therapeutics SA Common Shares stock beat Nasdaq index returns2025 Major Catalysts & Real-Time Stock Entry Alerts - newser.com
ADC Therapeutics SA stock outlook for YEARJuly 2025 Breakouts & Daily Technical Stock Forecast Reports - newser.com
ADC Therapeutics SA Hits New 52-Week High of $4.80 - Markets Mojo
Why retail traders accumulate ADC Therapeutics SA Common Shares stockWeekly Stock Recap & Weekly High Return Forecasts - newser.com
ADC Therapeutics SA (ADCT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is ADC Therapeutics SA showing signs of accumulationTreasury Yields & AI Powered Market Entry Strategies - newser.com
What indicators show strength in ADC Therapeutics SAQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com
Why analysts upgrade ADC Therapeutics SA stock2025 Year in Review & Proven Capital Preservation Tips - newser.com
Published on: 2025-11-01 01:08:52 - newser.com
ADC Therapeutics (NYSE:ADCT) Reaches New 1-Year HighTime to Buy? - MarketBeat
ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How to track smart money flows in ADC Therapeutics SA2025 Investor Takeaways & Target Return Focused Picks - newser.com
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is ADC Therapeutics SA stock bottoming outJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Is ADC Therapeutics SA stock cheap compared to fundamentalsWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Adc Therapeutics Sa (ADCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):